Source comparison
Nasal Spray vs Subcutaneous Injection
Most users choose nasal administration. The data supports this preference. Bioavailability 70-90% (estimated) 50-70% (estimated) Onset 10-15 minutes 15-30 minutes Dose range 200-900 mcg/day 250-500 mcg/day Convenience High (non-invasive) Lower (requires syring
This comparison does not assign a generated winner or score.
- Most users choose nasal administration. The data supports this preference.
- Bioavailability
- 70-90% (estimated)
- 50-70% (estimated)
- Onset
- 10-15 minutes
- 15-30 minutes
- Dose range
- 200-900 mcg/day
- 250-500 mcg/day
- Convenience
- High (non-invasive)
- Lower (requires syringe)
- CNS access
- More direct (bypasses BBB via olfactory nerve)
- Standard absorption pathway
- Primary use
- Anxiety, cognition
- Research settings
- Dose consistency
- Moderate (technique-dependent)
- High
- Nasal spray is preferred for two reasons. First, the olfactory nerve provides a more direct pathway to the brain, bypassing the blood-brain barrier partially. Second, the estimated bioavailability is actually higher for nasal administration than subcutaneous, which is unusual among peptides.
- Nasal administration tips: - Tilt head slightly forward (not backward). - Spray into nostril while gently inhaling. - Alternate nostrils between doses. - Wait 5 minutes before blowing nose. - Morning and early afternoon timing preferred. - Avoid evening dosing if sleep quality is affected (rare but reported).
- For injection technique, see our how to inject peptides guide. For nasal spray technique comparison, see our BPC-157 nasal spray guide.